Scientist Calls for Transparency in Scientific Funding and Innovation to Save Lives and Taxpayer Money
Dario Crosetto, an Italian-American scientist, challenges the scientific establishment for transparency and accountability in funding, highlighting the potential of his 3D-CBS invention to revolutionize cancer detection and reduce healthcare costs.
Dario Crosetto, an Italian-American scientist, has raised concerns over the lack of transparency and accountability in the scientific community, particularly in the allocation of taxpayer-funded research grants. Crosetto's invention, the 3D-CBS (3D Complete Body Screening), an advanced PET/CT technology, promises to significantly reduce premature cancer mortality and healthcare costs through early detection. Despite the potential benefits, Crosetto claims his innovations have been overlooked in favor of less efficient and more costly alternatives.
Crosetto's work is rooted in his earlier 3D-Flow invention, recognized in 1993 by an international review panel at Fermilab for its ability to detect objects traveling at the speed of light. This technology forms the basis of the 3D-CBS, which Crosetto argues could halve premature mortality rates if properly funded and implemented. However, he alleges that despite peer-reviewed approvals and successful demonstrations, his proposals have been consistently rejected in favor of projects that have later been deemed inadequate or impractical.
The scientist is calling for a public, face-to-face meeting with CERN's scientists to compare the efficiency and cost-effectiveness of his 3D-Flow system against CERN's FPGA-based systems. Crosetto's system, he claims, consumes significantly less power and is capable of executing over 8,000 programmable operations on each dataset arriving every 25 nanoseconds, at a fraction of the cost of CERN's current projects.
Crosetto's appeal for transparency and accountability extends beyond particle physics to the broader implications for medical imaging and cancer detection. He argues that the scientific community's resistance to open comparison and evaluation of competing technologies not only wastes billions in taxpayer money but also delays potential life-saving advancements in healthcare.
The call for a public scientific review is not just about correcting past oversights but ensuring that future research and development funds are allocated to projects that offer the greatest benefit to humanity. Crosetto's efforts highlight the need for a shift towards more transparent, evidence-based decision-making in scientific funding and innovation.